Nottingham Prognostic Index in Triple-Negative Breast Cancer
Author Information
Author(s): Albergaria André, Ricardo Sara, Milanezi Fernanda, Carneiro Vítor, Amendoeira Isabel, Vieira Daniella, Cameselle-Teijeiro Jorge, Schmitt Fernando
Primary Institution: Institute of Molecular Pathology and Immunology of Porto University (IPATIMUP)
Hypothesis
The Nottingham Prognostic Index may not be a reliable prognostic tool for triple-negative breast cancer due to its unique metastatic behavior.
Conclusion
The Nottingham Prognostic Index is a valid prognostic tool for predicting survival in triple-negative breast cancer patients.
Supporting Evidence
- Triple-negative breast cancer patients showed larger tumor sizes compared to other subtypes.
- Almost all triple-negative tumors were classified as grade 3.
- The Nottingham Prognostic Index effectively stratified survival outcomes in both triple-negative and non-triple-negative breast cancer.
Takeaway
This study shows that a tool used to predict breast cancer outcomes works well even for a tough type called triple-negative breast cancer.
Methodology
The study analyzed a series of breast cancer patients, focusing on the effectiveness of the Nottingham Prognostic Index in predicting outcomes for triple-negative versus non-triple-negative breast cancer.
Limitations
The study is retrospective and may not account for all variables affecting prognosis.
Participant Demographics
Patients aged 28 to 92 years, with a majority undergoing therapeutic surgery and/or chemotherapy.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% CI: 1.77 to 5.73
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website